Search & Analyze
Popular Searches
Advanced Enzyme Technologies Ltd.
Healthcare₹316.800.64%
24 Jul, 4:01 PM
CMP₹316.80
Mkt Cap₹3.52K Cr
P/E20.89
P/B2.17
ROE11.43%
52W High₹396.20
52W Low₹251.90
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
20.89
P/B Ratio
2.17
EV/EBITDA
12.94
Price/Sales
4.73
Dividend Yield (%)
1.70
EPS (TTM ₹)
15.07
Book Value (₹)
144.92
ROE (%)
11.43
ROCE (%)
15.27
ROA (%)
10.08
EBITDA Margin (%)
30.69
Net Profit Margin (%)
23.24
Debt/Equity
0.01
Current Ratio
9.78
Interest Coverage
63.28
Asset Turnover
0.43
Working Capital/Sales
0.80
Core EBITDA Growth (%)
15.95
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 5293.83 | 5406.37 | 6238.68 | 6369.1 | 7457.57 |
| Net Sales | 5293.83 | 5406.37 | 6238.68 | 6369.1 | 7457.57 |
| Total Income | 5358.03 | 5660.94 | 6608.42 | 6699.51 | 7815 |
| Total Expenditure | 3268.07 | 3831.37 | 4185.26 | 4413.98 | 5164.96 |
| Operating Profit | 2089.96 | 1829.57 | 2423.16 | 2285.53 | 2650.04 |
| Depreciation | 349.83 | 350.29 | 352.42 | 365.56 | 400.93 |
| Exceptional Items | — | -40.62 | -151.32 | — | 113.59 |
| Profit Before Tax | 1710.58 | 1403.88 | 1878.21 | 1873.64 | 2325.36 |
| Tax | 472.59 | 365.22 | 508.7 | 533.9 | 589.28 |
| Profit After Tax (PAT) | 1237.99 | 1038.66 | 1369.51 | 1339.74 | 1736.08 |
| EPS (₹) | 10.7 | 9.45 | 11.92 | 11.72 | 15.08 |
| Dividend Payout % | 50 | 50 | 255 | 260 | 267.5 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 223.6 | 223.65 | 223.65 | 223.76 | 223.85 |
| Reserves | 10655.93 | 12127.04 | 12987.32 | 13935.34 | 16004.13 |
| Shareholders Funds | 10885.92 | 12350.69 | 13241.28 | 14208.63 | 16319.57 |
| Total Debt | 109.4 | 132.39 | 251.12 | 215.36 | 205.28 |
| Total Liabilities | 12601.89 | 14105.05 | 15211.81 | 16111.55 | 18338.83 |
| Total Assets | 12601.89 | 14105.05 | 15211.81 | 16111.55 | 18338.83 |
| Book Value / Share | 97.3124 | 110.4466 | 118.1397 | 126.5561 | 144.9898 |
| Assets | 12601.89 | 14105.05 | 15211.81 | 16111.55 | 18338.83 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 1222.91 | 1403.62 | 1413.69 | 1424.97 | 1567.76 |
| Investing Activities | -37.87 | -2981.81 | -646.49 | -891.01 | -741.3 |
| Financing Activities | -485 | -257.98 | -592.38 | -725.44 | -703.66 |
| Net Cash Flow | 700.04 | -1836.17 | 174.82 | -191.48 | 122.8 |
ADVENZYMES
₹316.80
+0.64%